These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 21777274

  • 1. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
    de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ.
    J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
    [Abstract] [Full Text] [Related]

  • 2. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW, Frongillo F, Nicolotti N, Mulè A, Vennarecci G, De Simone P, Agnes S.
    Transplant Proc; 2009 Mar; 41(1):208-12. PubMed ID: 19249515
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, Stewart G, McCaughan G.
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [Abstract] [Full Text] [Related]

  • 4. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
    Teng da H, Zhu ZJ, Zheng H, Deng YL, Sun LY, Pan C, Liu YH, Song HL, Shen ZY.
    Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
    [Abstract] [Full Text] [Related]

  • 5. Impact of hepatic macrovesicular and microvesicular steatosis on the postoperative liver functions after right hepatectomy in living donors.
    Shin YH, Ko JS, Kim GS, Gwak MS, Sim WS, Lee AR, Yi HW, Joh JW.
    Transplant Proc; 2012 Mar; 44(2):512-5. PubMed ID: 22410058
    [Abstract] [Full Text] [Related]

  • 6. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
    Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD.
    Liver Transpl; 2010 Jul; 16(7):874-84. PubMed ID: 20583086
    [Abstract] [Full Text] [Related]

  • 7. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [Abstract] [Full Text] [Related]

  • 8. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW, Langnas AN.
    Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
    [Abstract] [Full Text] [Related]

  • 9. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers.
    Yersiz H, Lee C, Kaldas FM, Hong JC, Rana A, Schnickel GT, Wertheim JA, Zarrinpar A, Agopian VG, Gornbein J, Naini BV, Lassman CR, Busuttil RW, Petrowsky H.
    Liver Transpl; 2013 Apr; 19(4):437-49. PubMed ID: 23408461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, Minagawa R, Hiroshige S, Terashi T, Ninomiya M, Shiotani S, Harada N, Sugimachi K.
    Transplantation; 2003 Jul 27; 76(2):344-8. PubMed ID: 12883190
    [Abstract] [Full Text] [Related]

  • 13. Impact of center volume on outcomes of increased-risk liver transplants.
    Ozhathil DK, Li YF, Smith JK, Tseng JF, Saidi RF, Bozorgzadeh A, Shah SA.
    Liver Transpl; 2011 Oct 27; 17(10):1191-9. PubMed ID: 21604357
    [Abstract] [Full Text] [Related]

  • 14. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA.
    Ann Surg; 2007 Dec 27; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [Abstract] [Full Text] [Related]

  • 15. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation.
    Sharkey FE, Lytvak I, Prihoda TJ, Speeg KV, Washburn WK, Halff GA.
    Hum Pathol; 2011 Sep 27; 42(9):1337-42. PubMed ID: 21420717
    [Abstract] [Full Text] [Related]

  • 16. Combined Effect of Deceased Donor Macrovesicular and Microvesicular Steatosis on Liver Transplantation Outcomes: Analysis of SRTR Data Between 2010 and 2018.
    Ayloo S, Molinari M, Pentakota SR.
    Transplant Proc; 2021 Dec 27; 53(10):2971-2982. PubMed ID: 34740448
    [Abstract] [Full Text] [Related]

  • 17. Frozen-section diagnosis in donor livers: error rate estimation of steatosis degree.
    D'Alessandro E, Calabrese F, Gringeri E, Valente M.
    Transplant Proc; 2010 Dec 27; 42(6):2226-8. PubMed ID: 20692450
    [Abstract] [Full Text] [Related]

  • 18. The optimal number of donor biopsy sites to evaluate liver histology for transplantation.
    Frankel WL, Tranovich JG, Salter L, Bumgardner G, Baker P.
    Liver Transpl; 2002 Nov 27; 8(11):1044-50. PubMed ID: 12424718
    [Abstract] [Full Text] [Related]

  • 19. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation.
    Yoo HY, Molmenti E, Thuluvath PJ.
    Liver Transpl; 2003 Jan 27; 9(1):72-8. PubMed ID: 12514776
    [Abstract] [Full Text] [Related]

  • 20. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan 27; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.